Almenoff June Sherie 4
4 · TENAX THERAPEUTICS, INC. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Almenoff June Sherie
Director
Transactions
- Purchase
Common Stock
2025-11-17$7.15/sh+93$665→ 93 total - Purchase
Common Stock
2025-11-18$7.52/sh+1,900$14,280→ 1,993 total
Holdings
- 4
Stock Option (right to buy)
Exercise: $3200.00From: 2022-06-10Exp: 2031-06-10→ Common Stock (4 underlying) - 80,000
Stock Option (right to buy)
Exercise: $5.75From: 2026-07-01Exp: 2035-07-01→ Common Stock (80,000 underlying) - 4
Stock Option (right to buy)
Exercise: $992.00From: 2023-06-09Exp: 2032-06-09→ Common Stock (4 underlying) - 100,000
Stock Option (right to buy)
Exercise: $5.94From: 2025-12-10Exp: 2034-12-10→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $7.45 to $7.70. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.